![Shloma Yanai (R), CEO of Teva Pharmaceutical Industries Ltd. and Hans-Joachim Ziems, chairman of VEM Holding exchange a handshake prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Shloma Yanai (R), CEO of Teva Pharmaceutical Industries Ltd. and Hans-Joachim Ziems, chairman of VEM Holding exchange a handshake prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on](https://l450v.alamy.com/450v/2d1b4f2/shloma-yanai-r-ceo-of-teva-pharmaceutical-industries-ltd-and-hans-joachim-ziems-chairman-of-vem-holding-exchange-a-handshake-prior-to-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuterswolfgang-rattay-germany-tags-business-2d1b4f2.jpg)
Shloma Yanai (R), CEO of Teva Pharmaceutical Industries Ltd. and Hans-Joachim Ziems, chairman of VEM Holding exchange a handshake prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on
Dr Christine Kreutzer - Senior Director Strategic Innovation - Head of Teva Health Innovation Space - Teva Pharmaceuticals | LinkedIn
![Medicines of Teva held in front of the headquarters of ratiopharm in Ulm, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 Medicines of Teva held in front of the headquarters of ratiopharm in Ulm, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625](https://c8.alamy.com/comp/D56P2J/medicines-of-teva-held-in-front-of-the-headquarters-of-ratiopharm-D56P2J.jpg)